Cardiovascular Safety of VEGF-Targeting Therapies: Current Evidence and Handling Strategies

Por Girardi, Fabio, Franceschi, Enrico, Brandes, Alba A.
Publicado em 2010

Practical Management of Bevacizumab-Related Toxicities in Glioblastoma

Por Brandes, Alba A., Bartolotti, Marco, Tosoni, Alicia, Poggi, Rosalba, Franceschi, Enrico
Publicado no Oncologist (2015)

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology

Por Brandes, Alba A., Tosoni, Alicia, Spagnolli, Federica, Frezza, Giampiero, Leonardi, Marco, Calbucci, Fabio, Franceschi, Enrico
Publicado em 2008

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (<it>SNURF<...

Por Pession Annalisa, Ermani Mario, Tosoni Alicia, Marucci Gianluca, de Biase Dario, Franceschi Enrico, Morandi Luca, Tallini Giovanni, Brandes Alba
Publicado em 2010-02-01

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as...

Por Morandi, Luca, Franceschi, Enrico, de Biase, Dario, Marucci, Gianluca, Tosoni, Alicia, Ermani, Mario, Pession, Annalisa, Tallini, Giovanni, Brandes, Alba
Publicado em 2010

Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma

Por Brandes, Alba A., Nicolardi, Linda, Tosoni, Alicia, Gardiman, Marina, Iuzzolino, Paolo, Ghimenton, Claudio, Reni, Michele, Rotilio, Antonino, Sotti, Guido, Ermani, Mario
Publicado em 2006

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma

Por Schiffgens, Salveena, Wilkens, Ludwig, Brandes, Alba A., Meier, Tatiana, Franceschi, Enrico, Ermani, Mario, Hartmann, Christian, Sandalcioglu, Ibrahim Erol, Dumitru, Claudia A.
Publicado no Oncotarget (2016)

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Ne...

Por Brandes, Alba A., Tosoni, A., Franceschi, E., Blatt, V., Santoro, A., Faedi, M., Amistà, P., Gardiman, M., Labianca, R., Bianchini, C., Ermani, M., Reni, M.
Publicado em 2009

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma

Por Franceschi, Enrico, Stupp, Roger, van den Bent, Martin J., van Herpen, Carla, Laigle Donadey, Florence, Gorlia, Thierry, Hegi, Monika, Lhermitte, Benoit, Strauss, Lewis C., Allgeier, Anouk, Lacombe, Denis, Brandes, Alba A.
Publicado em 2012

Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment

Por Marchetti, Antonio, Del Grammastro, Maela, Felicioni, Lara, Malatesta, Sara, Filice, Giampaolo, Centi, Irene, De Pas, Tommaso, Santoro, Armando, Chella, Antonio, Brandes, Alba Ariela, Venturino, Paola, Cuccurullo, Franco, Crinò, Lucio, Buttitta, Fiamma
Publicado em 2014

AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Por Brandes, Alba A., Finocchiaro, Gaetano, Zagonel, Vittorina, Reni, Michele, Caserta, Claudia, Fabi, Alessandra, Clavarezza, Matteo, Maiello, Evaristo, Eoli, Marica, Lombardi, Giuseppe, Monteforte, Marta, Proietti, Emanuela, Agati, Raffaele, Eusebi, Vincenzo, Franceschi, Enrico
Publicado no Neuro Oncol (2016)

AT-18 SURVIVAL ANALYSIS OF PATIENTS WITH A PFS EVENT WHO DID NOT RECEIVE POST-PROGRESSION THERAPY IN AVAGLIO (BEVACIZUMAB [BEV] PLUS RADIOTHERAPY [RT] AND TEMOZOLOMIDE [TMZ] FOR NE...

Por Cloughesy, Tim, Wick, Wolfgang, Mason, Warren, Henriksson, Roger, Saran, Frank, Nishikawa, Ryo, Carpentier, Antoine F., Hoang-Xuan, Khe, Kavan, Petr, Cernea, Dana, Brandes, Alba A., Revil, Cedric, Abrey, Lauren, Chinot, Olivier L.
Publicado em 2014

A PHASE III RANDOMIZED CONTROLLED TRIAL OF SHORT-COURSE RADIOTHERAPY WITH OR WITHOUT CONCOMITANT AND ADJUVANT TEMOZOLOMIDE IN ELDERLY PATIENTS WITH GLIOBLASTOMA (NCIC CTG CE.6, EOR...

Por MD, James R. Perry, O'Callaghan, Christopher J., Ding, Keyue, Roa, Wilson, Mason, Warren P., Cairncross, J. Gregory, Brandes, Alba Ariela, Menten, Johan, Phillips, Claire, Fay, Michael F., Nishikawa, Ryo, Winch, Chad, Laperriere, Normand
Publicado em 2014

Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer

Por Passardi, Alessandro, Scarpi, Emanuela, Cavanna, Luigi, Dall'Agata, Monia, Tassinari, Davide, Leo, Silvana, Bernardini, Ilaria, Gelsomino, Fabio, Tamberi, Stefano, Brandes, Alba A., Tenti, Elena, Vespignani, Roberto, Frassineti, Giovanni L., Amadori, Dino, De Giorgi, Ugo
Publicado no Oncotarget (2016)

ET-12 PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Por Cloughesy, Tim, Finocchiaro, Gaetano, Belda-Iniesta, Cristobel, Recht, Lawrence, Brandes, Alba A, Pineda, Estela, Mikkelsen, Tom, Chinot, Olivier, Balana, Carmen, Macdonald, David, Westphal, Manfred, Hopkins, Kirsten, Weller, Michael, Bruey, Jean-Marie, Liu, Bo, Verret, Wendy
Publicado em 2014

Phase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European Organisation for Research and Treatment of Cancer Brain Tumor Group Study

Por Raymond, Eric, Brandes, Alba A., Dittrich, Christian, Fumoleau, Pierre, Coudert, Bruno, Clement, Paul M.J., Frenay, Marc, Rampling, Roy, Stupp, Roger, Kros, Johan M., Heinrich, Michael C., Gorlia, Thierry, Lacombe, Denis, van den Bent, Martin J.
Publicado em 2008

O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implicatio...

Por Brandes, Alba A., Franceschi, Enrico, Tosoni, Alicia, Bartolini, Stefania, Bacci, Antonella, Agati, Raffaele, Ghimenton, Claudio, Turazzi, Sergio, Talacchi, Andrea, Skrap, Miran, Marucci, Gianluca, Volpin, Lorenzo, Morandi, Luca, Pizzolitto, Stefano, Gardiman, Marina, Andreoli, Alvaro, Calbucci, Fabio, Ermani, Mario
Publicado em 2010

AT-11 FINAL RESULTS FROM THE RANDOMIZED PHASE II TRIAL AVAREG (ML25739) WITH BEVACIZUMAB (BEV) OR FOTEMUSTINE (FTM) IN RECURRENT GBM

Por Brandes, Alba A., Finocchiaro, Gaetano, Zagonel, Vittorina, Reni, Michele, Fabi, Alessandra, Caserta, Claudia, Clavarezza, Matteo, Maiello, Evaristo, Cartenì, Giacomo, Rosti, Giovanni, Eoli, Marica, Lombardi, Giuseppe, Monteforte, Marta, Agati, Raffaele, Eusebi, Vincenzo, Galli, Anna, Doria, Simona, Franceschi, Enrico
Publicado em 2014

NI-26 COMPARATIVE ANALYSIS OF THE RANO AND MACDONAD'S CRITERIA IN RECURRENT GLIOBLASTOMA TREATED IN THE RANDOMIZED PHASE II TRIAL AVAREG WITH BEVACIZUMAB OR FOTEMUSTINE.

Por Franceschi, Enrico, Agati, Raffaele, Finocchiaro, Gaetano, Zagonel, Vittorina, Fabi, Alessandra, Reni, Michele, Caserta, Claudia, Maiello, Evaristo, Cartenì, Giacomo, Clavarezza, Matteo, Rosti, Giovanni, Eoli, Marica, Lombardi, Giuseppe, Bacci, Antonella, Monteforte, Marta, Doria, Simona, Galli, Anna, Brandes, Alba A.
Publicado em 2014

NIMG-56 IMMUNOTHERAPY RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (iRANO): A REPORT OF THE RANO WORKING GROUP

Por Okada, Hideho, Weller, Michael, Huang, Raymond, Finocchiaro, Gaetano, Gilbert, Mark, Wick, Wolfgang, Ellingson, Benjamin, Hashimoto, Naoya, Pollack, Ian, Brandes, Alba, Franceschi, Enrico, Herold-Mende, Christel, Nayak, Lakshmi, Panigrahy, Ashok, Pope, Whitney, Prins, Robert, Sampson, John, Wen, Patrick, Reardon, David
Publicado no Neuro Oncol (2015)